N/A
Completed N=164
ACCESS: AI for pediatriC diabetiC Eye examS Study
Source: ClinicalTrials.gov NCT05131451 ↗Enrolled (actual)
164
Serious AEs
0.0%
Results posted
Nov 2023
Primary outcomePrimary: Number of Participants Who Get Screened With a Diabetic Eye Exam — 18; 81 Participants
Summary
The purpose of this study is to determine if providing in clinic point-of-care autonomous AI diabetic retinopathy exams improves screening rates compared to standard of care referral to an eye care provider, in a randomized control trial in a racially and ethnically diverse cohort of youth.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants Who Get Screened With a Diabetic Eye Exam |
18; 81 | — |
| SECONDARY Follow-up Rates With an Eye Care Provider |
18; 16 | — |
Eligibility Criteria
Inclusion Criteria
Meets American Diabetes Association (ADA) criteria for diabetic retinopathy screening:
- Diagnosis of Type 1 diabetes for ≥3 years, and age 11 or in puberty
- Diagnosis of Type 2 diabetes
Exclusion Criteria
- Diabetic eye exam within the last 6 months
- Known diabetic retinopathy
Data sourced from ClinicalTrials.gov (NCT05131451). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.